longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Fulgent Genetics

FLGT

21.5501.32% ( +0.280 )
Closed: Sep 24, 16:00:01 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -7.03, within the reasonable range, cheaper than 58.4% of the time in the past 5 years, and the industry ranks 45/74, the industry Median --.

-7.03xP/E
$21.55Stock price
$-3.07Earnings per share
-7.03xP/E
Stock price$21.55Earnings per share$-3.07

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-4.36x
Typical range
-14.28x–3.79x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-52.22x2.92%$23.68B
HIMSUSHims & Hers Health
-48.10x209.86%$6.83B
RDNTUSRadnet
-265.77x128.00%$5.61B
WGSUSGeneDx
-24.81x359.59%$2.64B
NEOUSNeogenomics
-48.44x64.73%$2.51B
AGLUSagilon health
-5.48x93.07%$1.27B
OPKUSOpko Health
-16.79x25.44%$1.22B
INNVUSInnovage
-475.46x2,301.70%$1.21B
CSTLUSCastle Biosciences
-55.37x53.28%$1.08B
LMRIUSLumexa Imaging
-34.23x145.51%$949.22M
FLGTUSFulgent Genetics
-7.03x42.64%$592.95M
GMRSUSGMR Solutions
-7.68x91.45%$581.27M
PREUSPrenetics Global
-8.36x16.63%$393.10M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-11.17x42.77%$310.20M
NAKAUSNakamoto
-0.42x102.50%$174.65M
AIRSUSAirSculpt Tech
-12.47x33.33%$146.35M
GAMGUSGlobal Asset Management Group, Inc.
-240.96x--$136.01M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-26.38x--$93.25M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.